Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from West Pharmaceutical Services

What Are Wall Street Analysts' Target Price for West Pharmaceutical Services Stock?

West Pharmaceutical Services has substantially underperformed the broader market over the past year, yet analysts remain bullish on the stock’s prospects, with price targets suggesting significant upside potential.

Barchart · Nov 21, 2025

5 Set It and Forget It Dividend Aristocrats for a Lifetime of Income

Five Dividend Aristocrats with decades of payout growth offer reliable income, resilient business models, and analyst-backed upside across sectors.

Barchart · Aug 29, 2025

Dividend Aristocrats Offer Safety in Market Storms. Buy These 2 Top-Rated Stocks Now.

Dividend Aristocrats bring the calm with steady paychecks, making these two 'Strong Buy'-rated stocks worth a second look here.

Barchart · May 15, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

These 2 Dividend Aristocrats Are Top Stocks to Buy in Times of Uncertainty

These companies offer consistent dividend growth and a strong industry presence.

Barchart · Apr 14, 2025

Is West Pharmaceutical Services Stock Underperforming the S&P 500?

West Pharmaceutical Services has lagged behind the broader S&P 500 Index over the past year, but analysts remain highly optimistic about its future growth potential.

Barchart · Mar 21, 2025

3 Top-Rated Dividend Aristocrats to Buy Now for Passive Income

These three companies have increased their dividends for 25-plus years and offer a mix of stability, growth potential, and attractive yields.

Barchart · Mar 12, 2025

Are Wall Street Analysts Predicting West Pharmaceutical Services Stock Will Climb or Sink?

West Pharmaceutical Services has underperformed the broader market over the past year, but Wall Street analysts remain optimistic about the stock’s prospects.

Barchart · Aug 26, 2024

Read news from The Economist, FT, and more,
with one subscription

3 Near-oversold Dividend Aristocrats To Buy Before They Pop

These three Dividend Aristocrats trade near oversold levels and offer reliable income and potential capital appreciation.

Barchart · May 21, 2024

5 Stocks With Rock-Solid Balance Sheets

As markets get wobbly amid a lack of interest rate clarity, Goldman Sachs has called out these 5 stocks for their industry-leading balance sheet strength.

Barchart · May 9, 2024

Coverage From

Barchart

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Places

United States

422,916 stories

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.